Doximity Announces Fiscal 2025 First Quarter Financial Results

Rhea-AI Summary

Doximity (NYSE: DOCS) reported strong fiscal 2025 Q1 results, with total revenue up 17% year-over-year to $126.7 million. The company saw significant growth in profitability, with net income increasing 46% to $41.4 million and adjusted EBITDA rising 42% to $65.9 million. Doximity's CEO highlighted record engagement, with 590,000 unique providers using their AI, telehealth, messaging, and scheduling tools. The company's non-GAAP net income margin improved to 44.1% from 37.5% year-over-year. For Q2 FY2025, Doximity expects revenue between $126.5-$127.5 million and adjusted EBITDA of $62.5-$63.5 million. The full-year FY2025 guidance projects revenue of $514-$523 million and adjusted EBITDA of $248.5-$257.5 million.

Positive

• Revenue increased 17% year-over-year to $126.7 million
• Net income grew 46% to $41.4 million
• Adjusted EBITDA rose 42% to $65.9 million
• Non-GAAP net income margin improved to 44.1% from 37.5%
• Record engagement with 590,000 unique providers using Doximity's tools

Negative

• Operating cash flow decreased 28% year-over-year to $41.2 million
• Free cash flow declined 29% year-over-year to $39.5 million

Financial Analyst

Doximity's Q1 FY2025 results demonstrate robust financial performance. The company's $126.7 million revenue represents a solid 17% YoY growth, while net income surged by 46%. The adjusted EBITDA growth of 42% YoY, reaching $65.9 million, is particularly impressive, indicating strong operational efficiency.

The company's margins are noteworthy, with net income margin expanding from 26.2% to 32.7% and adjusted EBITDA margin improving from 42.9% to 52.0%. These figures suggest Doximity is effectively scaling its operations and controlling costs.

However, the 28% decrease in operating cash flow and 29% decline in free cash flow warrant attention. Investors should monitor these metrics in future quarters to ensure they don't indicate underlying issues.

Tech Expert

Doximity's Q1 results highlight its growing influence in the digital healthcare space. The platform's engagement metrics are impressive, with 590,000 unique providers using its suite of AI, telehealth, messaging and scheduling tools. This record user engagement underscores the value proposition of Doximity's platform in streamlining healthcare workflows.

The company's focus on AI and telehealth aligns with broader industry trends towards digital transformation in healthcare. As these technologies become more integral to medical practice, Doximity's position as a leading digital platform for U.S. medical professionals could strengthen further.

Investors should keep an eye on how Doximity continues to innovate and expand its offerings to maintain its competitive edge in this rapidly evolving sector.

Market Research Analyst

Doximity's Q1 performance and forward guidance signal confidence in its market position. The company's FY2025 revenue guidance of $514-$523 million implies continued strong growth. This outlook, coupled with the projected adjusted EBITDA of $248.5-$257.5 million, suggests management's optimism about Doximity's ability to maintain its growth trajectory while improving profitability.

The company's success in attracting and engaging medical professionals is crucial. With 590,000 unique providers using its platform, Doximity is cementing its role as a vital tool in the healthcare ecosystem. This user base represents a significant portion of U.S. healthcare providers, offering potential for further monetization and service expansion.

Investors should monitor competitive pressures and regulatory changes in the digital health space, as these could impact Doximity's growth prospects.

Total revenues of $126.7 million, up 17% year-over-year

Net income growth of 46% and adjusted EBITDA growth of 42% year-over-year

SAN FRANCISCO--(BUSINESS WIRE)-- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2025 first quarter ended June 30, 2024.

“We were pleased to deliver strong profits and record engagement last quarter, as we beat on both our top and bottom lines,” said Jeff Tangney, co-founder and CEO of Doximity. “Last quarter, a record 590,000 unique providers used our AI, telehealth, messaging, and scheduling workflow tools to save time and better serve their patients.”

Fiscal 2025 First Quarter Financial Highlights

All comparisons, unless otherwise noted, are to the three months ended June 30, 2023.

• Revenue: Revenue of $126.7 million, versus $108.5 million, an increase of 17% year-over-year.
• Net income and non-GAAP net income: Net income of $41.4 million, versus $28.4 million, representing a margin of 32.7%, versus 26.2%. Non-GAAP net income of $55.9 million, versus $40.6 million, representing a margin of 44.1%, versus 37.5%.
• Adjusted EBITDA: Adjusted EBITDA of $65.9 million, versus $46.6 million, an increase of 42% year-over-year, representing adjusted EBITDA margins of 52.0%, versus 42.9%.
• Diluted net income per share and non-GAAP diluted net income per share: Diluted net income per share was $0.21, versus $0.13, while non-GAAP diluted net income per share was $0.28, versus $0.19.
• Operating cash flow and free cash flow: Operating cash flow of $41.2 million, versus $57.2 million, a decrease of 28% year-over-year, and free cash flow of $39.5 million, versus $55.6 million, a decrease of 29% year-over-year.

Financial Outlook

Doximity is providing guidance for its fiscal second quarter ending September 30, 2024 as follows:

• Revenue between $126.5 million and $127.5 million.
• Adjusted EBITDA between $62.5 million and $63.5 million.

Doximity is providing guidance for its fiscal year ending March 31, 2025 as follows:

• Revenue between $514 million and $523 million.
• Adjusted EBITDA between $248.5 million and $257.5 million.

Conference Call Information

Doximity posted prepared remarks on its investor relations website at https://investors.doximity.com. Doximity will host a webcast today at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss these financial results. To listen to a live audio webcast, please visit the Company’s Investor Relations page at https://investors.doximity.com. The archived webcast will be available on the Company’s Investor Relations page shortly after the call.

About Doximity

Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members include more than 80% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. Doximity's mission is to help doctors be more productive so they can provide better care for their patients.

Forward-Looking Statements

Statements we make in this press release may include statements which are not historical facts and are considered forward-looking within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act, which are usually identified by the use of words such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “may,” “plans,” “projects,” “seeks,” “should,” “will,” and variations of such words or similar expressions. We intend these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act and Section 21E of the Securities Exchange Act and are making this statement for purposes of complying with those safe harbor provisions. These forward-looking statements reflect our current views about our plans, intentions, expectations, strategies and prospects, which are based on the information currently available to us and on assumptions we have made. Although we believe that our plans, intentions, expectations, strategies and prospects as reflected in or suggested by those forward-looking statements are reasonable, we can give no assurance that the plans, intentions, expectations, or strategies will be attained or achieved. Furthermore, actual results may differ materially from those described in the forward-looking statements and will be affected by a variety of risks and factors including (i) the timing and scope of anticipated stock repurchases; (ii) the impact of uncertainty in the current economic environment and macroeconomic uncertainty; (iii) our ability to retain existing members or add new members to our platform and maintain or grow their engagement with our platform; (iv) our ability to attract new customers or retain existing customers; (v) the impact of our prioritization of our members’ interests; (vi) breaches in our security measures or unauthorized access to members’ data; (vii) our ability to maintain or manage our growth, and other risks and factors that are beyond our control including, without limitation, those set forth in the section entitled “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended March 31, 2024 and as may be updated in any subsequent Quarterly Reports on Form 10-Q. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could cause actual results to differ materially from those contained in our forward-looking statements. The forward-looking statements made in this press release relate only to management’s beliefs and assumptions as of this date. We assume no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

DOXIMITY, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
(unaudited)
		June 30, 2024				March 31, 2024
Assets
Current assets:
Cash and cash equivalents		$	111,442			$	96,785
Marketable securities			639,046				666,115
Accounts receivable, net			120,910				101,332
Prepaid expenses and other current assets			37,068				48,709
Total current assets			908,466				912,941
Property and equipment, net			12,869				12,318
Deferred income tax assets			44,742				45,068
Operating lease right-of-use assets			11,852				12,332
Intangible assets, net			26,256				27,317
Goodwill			67,940				67,940
Other assets			1,333				1,458
Total assets		$	1,073,458			$	1,079,374
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable		$	1,656			$	2,253
Accrued expenses and other current liabilities			28,488				43,703
Deferred revenue, current			102,943				99,145
Operating lease liabilities, current			2,190				2,149
Total current liabilities			135,277				147,250
Deferred revenue, non-current			116				211
Operating lease liabilities, non-current			11,841				12,397
Contingent earn-out consideration liability, non-current			5,349				10,895
Other liabilities, non-current			7,295				7,224
Total liabilities			159,878				177,977
Stockholders' Equity
Preferred stock			—				—
Common stock			186				187
Additional paid-in capital			841,470				823,885
Accumulated other comprehensive loss			(1,008	)			(2,664	)
Retained earnings			72,932				79,989
Total stockholders’ equity			913,580				901,397
Total liabilities and stockholders’ equity		$	1,073,458			$	1,079,374

DOXIMITY, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
(unaudited)
		Three Months Ended June 30,
		2024			2023
Revenue		$	126,676		$	108,469
Cost of revenue(1)			13,550			13,153
Gross profit			113,126			95,316
Operating expenses(1):
Research and development			22,574			21,931
Sales and marketing			35,244			34,455
General and administrative			9,255			9,247
Total operating expenses			67,073			65,633
Income from operations			46,053			29,683
Other income, net			7,116			4,839
Income before income taxes			53,169			34,522
Provision for income taxes			11,792			6,116
Net income		$	41,377		$	28,406
Net income per share attributable to Class A and Class B common stockholders:
Basic		$	0.22		$	0.15
Diluted		$	0.21		$	0.13
Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders:
Basic			185,610			194,521
Diluted			199,224			212,355

(1) Costs and expenses include stock-based compensation expense as follows (in thousands):
		Three Months Ended June 30,
		2024			2023
Cost of revenue		$	2,894		$	2,461
Research and development			4,684			3,256
Sales and marketing			6,586			5,995
General and administrative			2,926			2,289
Total stock-based compensation expense		$	17,090		$	14,001

DOXIMITY, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(unaudited)
		Three Months Ended June 30,
		2024				2023
Cash flows from operating activities
Net income		$	41,377			$	28,406
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization			2,562				2,604
Stock-based compensation, net of amounts capitalized			17,090				14,001
Non-cash lease expense			481				537
Accretion of discount on marketable securities, net			(2,360	)			(299	)
Net loss on sale of marketable securities			—				273
Amortization of deferred contract costs			2,726				2,667
Change in fair value of contingent earn-out consideration liability			202				269
Other			(738	)			(421	)
Changes in operating assets and liabilities:
Accounts receivable			(19,372	)			14,032
Prepaid expenses and other assets			10,460				2,589
Deferred contract costs			(1,431	)			(1,210	)
Accounts payable, accrued expenses and other liabilities			(12,942	)			677
Deferred revenue			3,704				(6,922	)
Operating lease liabilities			(516	)			(3	)
Net cash provided by operating activities			41,243				57,200
Cash flows from investing activities
Purchases of property and equipment			—				(70	)
Internal-use software development costs			(1,704	)			(1,494	)
Purchases of marketable securities			(170,413	)			(35,284	)
Maturities of marketable securities			202,058				116,649
Sales of marketable securities			—				37,525
Net cash provided by investing activities			29,941				117,326
Cash flows from financing activities
Proceeds from issuance of common stock upon exercise of stock options			2,551				3,285
Taxes paid related to net share settlement of equity awards			(2,394	)			(1,964	)
Repurchase of common stock			(51,214	)			(21,755	)
Payment of contingent consideration related to a business combination			(5,470	)			(5,390	)
Net cash used in financing activities			(56,527	)			(25,824	)
Net increase in cash and cash equivalents			14,657				148,702
Cash and cash equivalents, beginning of period			96,785				158,027
Cash and cash equivalents, end of period		$	111,442			$	306,729
Supplemental disclosures of cash flow information
Cash paid for taxes, net of refunds		$	12,907			$	—

Non-GAAP Financial Measures

To supplement our condensed consolidated financial statements, which are prepared and presented in accordance with accounting principles generally accepted in the United States (“GAAP”), the Company uses the following non-GAAP measures of financial performance:

• Non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating income, non-GAAP net income, non-GAAP net income margin, and non-GAAP basic and diluted net income per common share: We exclude the effect of stock-based compensation expense, amortization of acquired intangible assets, and change in fair value of contingent earn-out consideration liability from non-GAAP gross profit, non-GAAP gross margin and non-GAAP operating income. Non-GAAP net income and non-GAAP net income margin are further adjusted for estimated income tax on such adjustments. We calculate income taxes on the adjustments by applying an estimated annual effective tax rate to the adjustments. Non-GAAP basic and diluted net income per common share is non-GAAP net income attributable to common stockholders divided by the weighted average number of shares. For both basic and diluted non-GAAP net income per share, the weighted average shares we use in computing non-GAAP net income per share is equal to our GAAP weighted average shares. Non-GAAP gross margin represents non-GAAP gross profit as a percentage of revenue and non-GAAP net income margin represents non-GAAP net income as a percentage of revenue.
• Adjusted EBITDA and adjusted EBITDA margin: We define adjusted EBITDA as net income before interest, income taxes, depreciation, and amortization, and as further adjusted for stock-based compensation expense, change in fair value of contingent earn-out consideration liability, and other income, net. Net income margin represents net income as a percentage of revenue and adjusted EBITDA margin represents adjusted EBITDA as a percentage of revenue.
• Free cash flow: We calculate free cash flow as cash flow from operating activities less purchases of property and equipment and internal-use software development costs.

We use these non-GAAP financial measures internally for financial and operational decision-making purposes and as a means to evaluate period-to-period comparisons. Non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP financial measures and should be read only in conjunction with our condensed consolidated financial statements prepared in accordance with GAAP. Our presentation of non-GAAP financial measures may not be comparable to similar measures used by other companies. We encourage investors to carefully consider our results under GAAP, as well as our supplemental non-GAAP information and the reconciliation between these presentations, to more fully understand our business. Please see the tables included at the end of this release for the reconciliation of GAAP to non-GAAP results.

Key Business Metrics

• Net revenue retention rate: Net revenue retention rate is calculated by taking the trailing 12-month (“TTM”) subscription-based revenue from our customers that had revenue in the prior TTM period and dividing that by the total subscription-based revenue for the prior TTM period. For the purposes of this calculation, subscription revenue excludes subscriptions for individuals and small practices and other non-recurring items. Our net revenue retention rate compares our subscription revenue from the same set of customers across comparable periods, and reflects customer renewals, expansion, contraction, and churn. Our net revenue retention rate is directly tied to our revenue growth rate and thus fluctuates as that growth rate fluctuates.
• Customers with trailing 12-month subscription revenue greater than $500,000: The number of customers with TTM subscription revenue greater than $500,000 is a key indicator of the scale of our business, and is calculated by counting the number of customers that contributed more than $500,000 in subscription revenue in the TTM period. Our customer count is subject to adjustments for acquisitions, consolidations, spin-offs, and other market activity, and we present our total customer count for historical periods reflecting these adjustments.

Reconciliation of GAAP to Non-GAAP Financial Measures

The following tables reconcile the specific items excluded from GAAP metrics in the calculation of non-GAAP metrics for the periods shown below:

		Three Months Ended June 30,
		2024				2023
		(unaudited)
		(in thousands, except percentages)
Net income		$	41,377			$	28,406
Adjusted to exclude the following:
Stock-based compensation			17,090				14,001
Depreciation and amortization			2,562				2,604
Provision for income taxes			11,792				6,116
Change in fair value of contingent earn-out consideration liability			202				269
Other income, net			(7,116	)			(4,839	)
Adjusted EBITDA		$	65,907			$	46,557
Revenue		$	126,676			$	108,469
Net income margin			32.7	%			26.2	%
Adjusted EBITDA margin			52.0	%			42.9	%

		Three Months Ended June 30,
		2024				2023
		(unaudited)
		(in thousands)
Net cash provided by operating activities		$	41,243			$	57,200
Purchases of property and equipment			—				(70	)
Internal-use software development costs			(1,704	)			(1,494	)
Free cash flow		$	39,539			$	55,636
Other cash flow components:
Net cash provided by investing activities		$	29,941			$	117,326
Net cash used in financing activities		$	(56,527	)		$	(25,824	)

		Three Months Ended June 30,
		2024				2023
		(unaudited)
		(in thousands, except per share data and percentages)
GAAP cost of revenue		$	13,550			$	13,153
Adjusted to exclude the following:
Stock-based compensation			(2,894	)			(2,461	)
Amortization of acquired intangibles			—				(137	)
Non-GAAP cost of revenue		$	10,656			$	10,555
GAAP gross profit		$	113,126			$	95,316
Adjusted to exclude the following:
Stock-based compensation			2,894				2,461
Amortization of acquired intangibles			—				137
Non-GAAP gross profit		$	116,020			$	97,914
GAAP gross margin			89.3	%			87.9	%
Non-GAAP gross margin			91.6	%			90.3	%
GAAP research and development expense		$	22,574			$	21,931
Adjusted to exclude the following:
Stock-based compensation			(4,684	)			(3,256	)
Non-GAAP research and development expense		$	17,890			$	18,675
GAAP sales and marketing expense		$	35,244			$	34,455
Adjusted to exclude the following:
Stock-based compensation			(6,586	)			(5,995	)
Amortization of acquired intangibles			(1,061	)			(1,061	)
Change in fair value of contingent earn-out consideration liability			(202	)			(269	)
Non-GAAP sales and marketing expense		$	27,395			$	27,130
GAAP general and administrative expense		$	9,255			$	9,247
Adjusted to exclude the following:
Stock-based compensation			(2,926	)			(2,289	)
Non-GAAP general and administrative expense		$	6,329			$	6,958
GAAP operating expense		$	67,073			$	65,633
Adjusted to exclude the following:
Stock-based compensation			(14,196	)			(11,540	)
Amortization of acquired intangibles			(1,061	)			(1,061	)
Change in fair value of contingent earn-out consideration liability			(202	)			(269	)
Non-GAAP operating expense		$	51,614			$	52,763
GAAP operating income		$	46,053			$	29,683
Adjusted to exclude the following:
Stock-based compensation			17,090				14,001
Amortization of acquired intangibles			1,061				1,198
Change in fair value of contingent earn-out consideration liability			202				269
Non-GAAP operating income		$	64,406			$	45,151
GAAP net income		$	41,377			$	28,406
Adjusted to exclude the following:
Stock-based compensation			17,090				14,001
Amortization of acquired intangibles			1,061				1,198
Change in fair value of contingent earn-out consideration liability			202				269
Income tax effect of non-GAAP adjustments (1)			(3,854	)			(3,248	)
Non-GAAP net income		$	55,876			$	40,626
Non-GAAP net income margin			44.1	%			37.5	%
Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders:
Basic			185,610				194,521
Diluted			199,224				212,355
Non-GAAP net income per share attributable to Class A and Class B stockholders:
Basic		$	0.30			$	0.21
Diluted		$	0.28			$	0.19

(1)

For the three months ended June 30, 2024 and 2023, management used an estimated annual effective non-GAAP tax rate of 21.0%.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20240808776516/en/

Investor Relations Contact:

Perry Gold

ir@doximity.com

Media Contact:

Amanda Cox

pr@doximity.com

Source: Doximity

FAQ

What was Doximity's (DOCS) revenue for Q1 fiscal 2025?

Doximity reported revenue of $126.7 million for Q1 fiscal 2025, representing a 17% increase year-over-year.

How much did Doximity's (DOCS) net income grow in Q1 fiscal 2025?

Doximity's net income grew by 46% year-over-year to $41.4 million in Q1 fiscal 2025.

What is Doximity's (DOCS) revenue guidance for fiscal year 2025?

Doximity provided revenue guidance for fiscal year 2025 between $514 million and $523 million.

How many unique providers used Doximity's (DOCS) tools in Q1 fiscal 2025?

A record 590,000 unique providers used Doximity's AI, telehealth, messaging, and scheduling workflow tools in Q1 fiscal 2025.